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Abstract
During the development of the mouse lung, the expression of a number of genes, including those encoding growth factors and
components of their downstream signaling pathways, is enriched in the epithelium and/or mesenchyme of the distal buds. In this location,
they regulate processes such as cell proliferation, branching morphogenesis, and the differentiation of specialized cell types. Here, we report
that the expression of Pea3 and Erm (or Etv5, Ets variant gene 5), which encode Pea3 subfamily ETS domain transcription factors, is
initially restricted to the distal buds of the developing mouse lung. Erm is transcribed exclusively in the epithelium, while Pea3 is expressed
in both epithelium and mesenchyme. Erm/Pea3 are downstream of FGF signaling from the mesenchyme, but their responses toward
different FGFs are not the same. The functions of the two proteins were investigated by transgenic expression of a repressor form of Erm
specifically in the embryonic lung epithelium. When examined at E18.5, the distal epithelium of transgenic lungs is composed predomi-
nantly of immature type II cells, while no mature type I cells are observed. In contrast, the differentiation of proximal epithelial cells,
including ciliated cells and Clara cells, appears to be unaffected. A model is proposed for the role of Pea3/Erm during the dynamic process
of lung bud outgrowth and proximal–distal differentiation, in response to FGF signaling. Our results provide the first functional evidence
that Pea3 subfamily members play a role in epithelial–mesenchymal interactions during lung organogenesis.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Mouse lung development starts from E9.5 when two
primordial buds appear in the ventral foregut just anterior to
the stomach. It can be histologically divided into four
stages: (1) the pseudoglandular stage (E9.5–E16.5), when
the bronchial and respiratory tree is formed from the pri-
mordial buds and is lined with epithelial precursor cells, (2)
the canalicular stage (E16.5–E17.4), (3) the terminal sac
stage (E17.4 to P5), and (4) the alveolar stage (P5–P30).
During the later stages, the precursor cells differentiate into
various cell types lining the proximal and distal airways,
followed by the formation of alveoli and a mature vascular
system (reviewed in Warburton et al., 2000).
Between E9.5 and E16.5, the primary buds undergo
repeating rounds of outgrowth and branching, leading to a
tree-like structure. Coincident with morphological changes,
the lung buds also undergo proximal–distal patterning. In
the case of the epithelium, this leads to the differentiation of
the unspecialized, multipotent endodermal precursor cells
into the mature cell types characteristic of the proximal and
distal airways (Warburton et al., 2000). In vivo cell lineage
studies indicate that the epithelial precursors for the trachea
and large bronchi versus more peripheral airways are seg-
regated at a relatively early stage (before E11.5) (Perl et al.,
2002). However, transplantation experiments demonstrate
that the epithelial precursor cells are able to differentiate
along alternative pathways in response to diffusible mole-
cules produced by the mesenchyme from different parts of
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the embryonic lung (Wessells et al., 1970; Shannon et al.,
1994, 1998). Further studies indicate that the processes of
branching morphogenesis, proximal–distal patterning, and
differentiation are regulated by reciprocal interactions be-
tween the epithelial cells, the surrounding mesenchyme, and
the outermost mesothelium, mediated by extracellular sig-
naling molecules, cell membrane–bound receptors, and in-
tracellular signaling pathways (for review, see Hogan et al.,
1997; Hogan and Yingling, 1998; Warburton et al., 2000;
Cardoso, 2001).
From previous studies, it is known that members of
several conserved families of signaling molecules, includ-
ing the FGF, Hh, Bmp/TGF, Wnt, EGF, and PDGF fam-
ilies, are expressed specifically in the distal tips of the
developing lung (see reviews cited above). These structures
therefore behave as “signaling centers,” modulating and
driving the process of branching morphogenesis as well as
proximal–distal differentiation. For example, Fgf10 is ex-
pressed in the mesenchyme just adjacent to the bud tip and
acts as a chemoattractant factor directing lung bud out-
growth (Bellusci et al., 1997; Min et al., 1998; Sekine et al.,
1999; Lebeche et al., 1999; Weaver et al., 2000). Other Fgfs
expressed in the embryonic lung include Fgf1 Fgf2, Fgf7,
Fig. 1. Spatial and temporal expression patterns of Erm and Pea3 during
lung development. (A–F) Whole mount and (G–L) radioactive section in
situ hybridization. Erm is expressed in the distal lung endoderm at E10.5
(A), and continues at E11.5 (B, C), E13.5 (G), E15.5 (I), and E18.5 (K).
Pea3 is expressed in distal lung endoderm and mesoderm at E10.5 (D), and
continues at E11.5 (E, F), E13.5 (H), E15.5 (J), and E18.5 (L). (C, F) Erm
is expressed in distal endoderm (C), while Pea3 is expressed in distal
endoderm and mesoderm (star) (F). Scale bar, 100 m for (A) and (D) 150
m for (B) and (E), 180 m for (C) and (F), 100 m for (G–L).
Fig. 2. Regulation of Pea3/Erm expression by FGF7 and FGF10 in mes-
enchyme-free endoderm culture. Distal endoderm buds from E11.5 lungs
were cultured in Matrigel for 48 h with 20 ng/ml FGF7 (A, C, E, G, I) or
250 ng/ml FGF10 (B, D, F, H, J). After culture, the samples were released
from the Matrigel by enzyme treatment and the expression of distal marker
genes examined by lacZ staining for Bmp4-lacZ (C, D), or by in situ
hybridization for SpC (E, F), Pea3 (G, H), and Erm (I, J). Scale bar, 100
m.
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Fgf9, and Fgf18 (Gonzalez et al., 1990; Fu et al., 1991; Han
et al., 1992; Mason et al., 1994; Finch et al., 1995; Bellusci
et al., 1997; Hu et al., 1998; Ohbayashi et al., 1998; Colvin
et al., 2001; Hyatt et al., 2002). Fgf7 is expressed in lung
mesenchyme (Mason et al., 1994; Bellusci et al., 1997;
Lebeche et al., 1999), and is thought to participate in the
specification of distal epithelial cell types (Ulich et al.,
1994; Shiratori et al., 1996; Cardoso et al., 1997; Shannon
et al., 1999; Hyatt et al., 2002). Fgf9 is initially expressed in
the epithelium and mesothelium, and later is restricted to the
mesothelium, where it is thought to be responsible for main-
taining Fgf10 expression and proliferation of the underlying
mesodermal (Colvin et al., 2001).
Many ETS domain transcription factors are known to be
downstream of FGF signaling (for review, see Sharrocks,
2001). Recently, we identified from a subtractive hybridiza-
tion and differential screen two members of the Pea3 sub-
family of ETS factors, Pea3 and Erm, as being specifically
expressed in distal, but not proximal, lung buds epithelium
at E11.5 (Liu et al., 2002). This finding is consistent with
previous reports on the expression of the two genes in lung
(Chotteau-Lelievre et al., 1997; de Launoit et al., 1997). The
Pea3 subfamily includes three members: Pea3, Erm (or
Etv5, Ets variant gene 5), and Er81 (or Etv1, Ets variant
gene 1). All three have a 72-amino-acid N-terminal tran-
scription activation domain, an 85-amino-acid winged he-
lix–turn–helix ETS DNA binding domain, and a short C-
terminal domain. They recognize similar DNA sequences
flanking the core GGAA/T binding sequence and act as
transcriptional activators (Laget et al., 1995; de Launoit et
al., 1997 Bojovic et al., 2001). The subfamily has been
implicated in various cellular processes, including prolifer-
ation, differentiation, and tumorigenesis (Bartel et al., 2000;
Maroulakou and Bowe, 2000; Sharrocks, 2001). For exam-
ple, members are overexpressed in oncogene-induced
mouse mammary tumors, and expression of an inhibitor
form of Pea3 reduces the size and number of tumors (Shep-
herd et al., 2001). In the nervous system, studies have
shown that Pea3 and Er81 are differentially expressed in
motor neuron pools in the chick spinal cord, as well as in
subsets of muscle sensory neurons. The motor and sensory
neurons innervating the same muscle express the same Pea3
member, and this expression pattern is required for the
formation of functional circuits (Lin et al., 1998; Arber et
al., 2000; Price et al., 2002). During organogenesis, Pea3
genes are differentially expressed in the mesenchyme and
epithelium of the developing lung, salivary gland, gut, ol-
factory and otic organs (Chotteau-Lelievre et al., 1997).
While Erm and Pea3 are primarily expressed in the devel-
oping epithelium, Er81 is mostly confined to the surround-
ing mesenchyme (Chotteau-Lelievre et al, 1997). Their ex-
pression patterns suggest that they participate in epithelial–
mesenchymal interactions, but their specific roles in
organogenesis have not been investigated previously. All
three members have been genetically inactivated in mice.
Erm null mutants die at E9.5, before the onset of the mor-
Fig. 3. Expression of Erm and Pea3 is regulated by FGF signaling in the
intact lung. FGF or BSA-soaked beads were implanted in the mesoderm of
E11.5 lungs. After 24–48 h, gene expression was assayed by whole-mount
in situ hybridization. (A, C, E, G, I) Erm expression. (B, D, F, H, J) Pea3
expression. Beads were saturated with BSA (A, B); FGF7 (C, D); FGF10
(E, F); FGF9 (G, H); and FGF2 (I, J). Arrowheads indicate ectopic
expression of Erm/Pea3. Yellow circles indicate the position of the im-
planted beads. Scale bar, 400 m.
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phogenetic events involved in lung and other organ devel-
opment (T. Jessel, personal communication). Pea3/ and
Er81/ mice both survive after birth, and apparently do
not have major organogenesis defects (Arber et al., 2000;
Laing et al., 2000), suggesting that Pea3 members have
redundant functions during organ development.
Here, we study the function of Pea3/Erm during lung
development by expressing a dominant repressor form of
Erm specifically in the epithelium. Our results are consistent
with the idea that Erm/Pea3 are downstream targets of FGF
signaling from the mesoderm and function to promote or
maintain the phenotype of distal epithelial cells.
Materials and methods
Lung explant culture
Embryonic lungs of ICR mice (Harlan-Sprague-Dawley,
Indianapolis) were dissected at E11.5. For mesenchyme-
free endoderm culture, distal endoderm was isolated after
treatment with pancreatin/trypsin solution and cultured in
growth factor reduced Matrigel in medium supplemented
with 20 ng/ml FGF7 or 250 ng/ml FGF10 (Bellusci et al.,
1997). Bud length was determined from 10 samples under
each condition. Endoderm was harvested after 48 h by
treatment with Matrisperse enzyme (BD Bioscience; Hyatt
et al., 2002), fixed with 4% paraformaldehyde in PBS, and
processed for in situ hybridization or -galactosidase stain-
ing.
Intact E11.5 lungs were cultured for 24–48 h at 37°C in
5% CO2 on Nuclepore polycarbonate filters (Whatman)
floating on 500 l medium (50% DMEM: 50% Ham’s F12,
0.1% BSA, 0.05 U/ml penicillin, 0.05 g/ml streptomycin).
FGF- and BSA-soaked beads, prepared as described
(Weaver et al., 2000), were implanted in the mesenchyme
adjacent to proximal endoderm. FGFs were obtained from R
& D Systems. At least two lungs were examined for each
condition and the experiments repeated at least twice.
Luciferase reporter assay
Each well of a 24-well plate was seeded with 1.5  106
HEK293 cells or 1.0  106 Immorto mouse C3 cells. The
latter epithelial cell line was derived from adult lungs of the
transgenic H-2Kb-tsA58 (Immorto) mouse strain (Jat et al.,
1991) by Dr. Robert Whitehead (Vanderbilt Medical Cen-
ter, Nashville, TN) and was grown in the presence of 2.5
U/ml IFN- (Calbiochem). Approximately 20 h later, the
cells in each well were transfected with 80 ng of a Pea3-
responsive luciferase reporter containing 5 reiterations of a
functional ETS binding site (AACGAGGAAGTATTA)
cloned upstream of the minimal thymidine kinase promoter
of the plasmid TK-Luc. This ETS site has been shown to be
responsible for Pea3 subfamily transactivation of the matri-
lysin promotor (Crawford et al., 2001). Included in each
transfection mix was 160 ng of either empty pCDNA3,
pCS2-EngR, pFLAG-CMV-Erm290-489, or pFLAG-CMV-
EngR-Erm290-489. For some experiments, the reporter was
stimulated by including 80 ng of a CMV-promoter driven
expression vector for wild type Erm. Total DNA was kept
constant with empty pCDNA3 vector. Each transfection
mix included 1 ng of CMV-RL reporter (Promega) to nor-
malize for transfection efficiency. Cells were lysed 24 h
later and assayed by using the Dual Luciferase Kit (Pro-
mega), according to the manufacture’s directions. Each as-
say was performed in triplicate.
Generation of transgenic mice
A full-length mouse Erm cDNA (I.M.A.G.E. clone
#3665646) was cloned into the EcoRI site of the human
3.7-kb SpC/SV40-small-T-intron/polyA vector. This regu-
latory element of SpC (Sftpc, here designated as SpC) spe-
cifically drives transgene expression in distal epithelium
from E10.5, but high level of expression in these cells and
in Type II cells is only achieved after E15.5 (Wert et al.,
1993; and data not shown). For generating truncated Erm,
only sequences corresponding to amino acids 290–489
were cloned into the vector. For the repressor form of Erm
(EngR-Erm), the cDNA corresponding to amino acids 290
to 489 was inserted at the Xho and Xba sites into the
pCS2-EngR plasmid containing the Drosophila Engrailed
repressor domain (kindly provided by Dr. Gerald H. Thom-
sen). The Eng-Erm 290–489 fragment was then removed
by digesting with ClaI and XbaI, blunt ended, and inserted
into the SpC/SV40 vector, which had been linearized by
SalI and EcoRI. All PCR products were sequenced.
The expression cassette was excised with NdeI and NotI
for the full-length and truncated Erm, and with NdeI and
SmaI for the repressor form of Erm. Transgenic embryos
were generated as described (Weaver et al., 1999) and
identified by PCR using the following primers: 5-AGGAA-
CAAACAGGCTTCAAA-3 (SpC promotor for 5), and
5-TGGCTACAGGACGACAACTCG-3 (for full-length
Erm), 5-AGGAGGCCCCTCTCGATACAT-3 (for the
truncated Erm 290–489), and 5-CACATCCACATCAAT-
GTCGT-3 (for EngR-Erm). For full-length and truncated
Erm, two and five transgenic embryos were obtained, re-
spectively. Nine SpC-EngR-Erm transgenic embryos were
obtained at E18.5, and six of them showed an abnormal lung
phenotype. One transgenic lung was harvested at E17.5 and
showed the same abnormalities. No difference was seen in
the overall size of the transgenic versus nontransgenic pups.
In situ hybridization
Whole-mount in situ hybridization was performed by
using digoxygenin-labeled antisense riboprobes as de-
scribed (Bellusci et al., 1997).
For section in situ hybridization, 35S-labeled probes were
prepared from the following templates: the 0.4-kb fragment
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of small T antigen (Wert et al., 1993), 2.4-kb Foxj1 (Hackett
et al., 1995), 0.68-kb SpC (Wert et al., 1993), 0.454-kb rat
CC10 (Scgblal, also known as CCSP or uteroglobin) (Wert
et al., 1993), and 0.35-kb mouse Aquaporin-5 (Ramirez et
al., 2000). Sections of transgenic and control lungs were
processed at the same time. To quantitate the proportion of
proximal airways in control and SpC-EngR-Erm transgenic
lungs, four sections corresponding to similar regions of
control and two transgenic lungs were examined. The ratio
of proximal and distal airways was measured by comparing
Foxj1-expressing area to the total area of the lung using
NIH-image software. About 10% of the total area of control
lungs and 25% of the total area of transgenic lungs express
Foxj1.
Electron microscopy
Electron microscopy was performed as previously de-
scribed (Weaver et al., 1999). Briefly, control and trans-
genic lung tissue was cut into 1- to 2-mm3 pieces and fixed
in 2% glutaraldehyde in phosphate buffer. After dehydra-
tion, the tissues were embedded in Spurr (Ted Pella, Red-
ding, CA). Semithin sections were stained with ethylene
blue and examined with light microscopy to select the field
for ultrathin sectioning. Ultrathin sections were mounted on
uncoated copper mesh grids, counterstained with uranyl
acetate-lead, and examined using a Philips 300 electron
microscope.
Antibody and -galactosidase staining
Sections were dewaxed and rehydrated and, for antigen
unmasking, heated to about 80°C in a microwave oven in 10
mM NaCitrate buffer (pH 6). After blocking in 5% normal
donkey serum in PBS, sections were incubated overnight
with primary antibody at 4°C and, after washing, with
Cy3-conjugated secondary antibody. Nuclei were stained
with 0.1 g/ml DAPI for 5 min. The phosphohistone H3
antibody was from Upstate Technology and used at 1:500
dilution. The cleaved caspase-3 antibody was from Cell
Signaling and was diluted to 1:50. Detection of pre-CC10
was kindly performed by Dr. Mildred Stahlman using anti-
body generously supplied by Dr. Jeffrey Whitsett (Whitsett
et al., 2002).
-Galactosidase staining was performed as described
(Weaver et al., 2000).
Estimation of cell proliferation
To estimate epithelial cell proliferation, nuclei with pos-
itive phosphohistone H3 staining were scored in sections
double stained with anti-phosphohistone H3 and DAPI.
Distal and proximal airways were distinguished by mor-
phology. Since squamous type I cells are difficult to distin-
guish from mesodermal cells in histological sections of
E18.5 lungs, only nuclei immediately abutting the lumen of
the sacs were scored as belonging to distal epithelial cells.
For transgenic lungs, 43 phosphohistone positive nuclei
were identified out of a total of 4173 nuclei. For control
lungs, 10 phospho-histone positive nuclei were found out of
4923 counted. The mitotic index is calculated as the number
of phosphohistone-positive nuclei per 100 nuclei counted. A
similar method was used to compare the cell proliferation
rate of proximal epithelial cells.
Results
Pea3 and Erm expression in the developing lung
From a subtractive hybridization and differential screen
(Liu et al., 2002), Erm was identified as being specifically
transcribed in distal, but not proximal, epithelium of the
E11.5 mouse lung. Although transcription of Erm and other
Pea3 subfamily ETS genes has been detected previously in
the embryonic lung (Chotteau-Lelievre et al., 1997; de
Launoit et al., 1997), their precise spatial and temporal
expression patterns in relation to branching morphogenesis
have not been investigated. As illustrated in Fig. 1A–F, we
find that both Erm and Pea3 are expressed in the endoderm
at the tips of the buds from the time they first emerge
(E10.5), while Pea3 is also expressed in the overlying
mesoderm. Section in situ hybridization shows that expres-
sion of both Erm and Pea3 continues up to at least E18.5 in
cells of the distal airways (Fig. 1G–L).
Expression of Erm and Pea3 is positively regulated by
FGFs
Pea3 proteins are posttranslationally modified in re-
sponse to the MAPK and PKA signaling pathways
(Janknecht et al., 1996), and in zebrafish Erm and Pea3 are
downstream of FGF signaling in the hindbrain (Raible and
Brand, 2001; Roehl and Nusslein-Volhard, 2001). We
therefore investigated the effect of FGF7 and FGF10 on
Erm and Pea3 expression in mesenchyme-free, distal lung
epithelium cultured in Matrigel. In this culture system, the
epithelium responds differently to these two FGFs. When
20 ng/ml FGF7 is added to the medium, the endoderm
initially forms a cyst, which then develops numerous small
buds (about 60 m long) at the surface. In response to
higher concentrations of FGF7 (250 ng/ml), the endoderm
forms a large cyst without buds. In contrast, when 250
ng/ml FGF10, which is the lowest concentration to keep the
endoderm healthy, is added to the culture, the endoderm
gives rise to fewer, more elongated buds (about 150 m
long) and less cyst expansion (Fig. 2A and B; Bellusci et al.,
1997). In addition, FGF7 and FGF10 have different effects
on gene expression in this culture system. Our results indi-
cate that Bmp4 and SpC expression are induced to much
higher levels by 20 ng/ml FGF7 than 250 ng/ml FGF10
(Fig. 2C–F), which is consistent with previous finding
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(Hyatt et al., 2002). Significantly, FGF7 gives stronger
induction of Pea3/Erm expression than FGF10, and this
effect is particularly striking for Pea3 (Fig. 2G–J).
To see if this differential response is a feature of the
Matrigel culture system or is also seen in intact lung tissue,
we used a whole lung organ culture system in which FGF-
Fig. 4. Generating transgenic lungs expressing a repressor form of Erm. (A) The activation domain of Erm was replaced by the repressor domain of
Drosophila Engrailed (a.a. 1-298). This engineered cDNA was subcloned into the transgene vector, downstream of the 3.7-kb human SpC promoter, and
upstream of the SV40 intron/polyA. (B, C) In vitro assays using a Pea3 responsive luciferase reporter (Crawford et al., 2001) show that, in both HEK 293
cells (B) and Immorto mouse C3 lung epithelial cells (C), full-length Erm acts as a transcriptional activator, while EngR-Erm acts as a repressor that
effectively counteracts Erm activity. (B) In HEK 293 cells, wild type Erm acts as a transactivator and increases the expression of the luciferase reporter gene
by more than 2.5-fold compared with vector alone control. While the Engrailed domain by itself (EngR) does not have any effect, EngR-Erm strongly
represses the expression of the reporter gene, and delta Erm (truncated Erm 290-489) only slightly decreases the luciferase activity. When coexpressed with
wild-type Erm, EngR by itself has little effect, while EngR-Erm very strongly, and delta Erm only slightly, represses Erm activity. (C) Similar results are
obtained in Immorto mouse C3 lung epithelial cells. Wild-type Erm acts as a transactivator, EngR-Erm represses the expression of the reporter gene, and also
effectively counteracts Erm when coexpressed with full-length wild-type protein. (D, E) Macroscopic phenotype of a typical E18.5 transgenic (E) compared
with nontransgenic (D) lung. (F, G) Section in situ hybridization of tissue from the peripheral region of control (F) and transgenic (G) lung, using SV40 T
intron as probe. Scale bar, 1.5 mm for (D) and (E), and 50 m for (F) and (G).
15Y. Liu et al. / Developmental Biology 261 (2003) 10–24
Fig. 5. Histological examination of E18.5 control and transgenic lungs. Sections of control (A, C) and transgenic (B, D) lungs were stained with heamatoxylin
and eosin. (A, B) Low magnification images, and (C, D) high magnification images of the distal part of the lung (green squares in A and B). Scale bar, 200
m for (A) and (B), 50 m for (C) and (D).
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saturated beads are implanted in the mesenchyme adjacent
to proximal endoderm, where the genes are not normally
transcribed. As shown in Fig. 3C and D, FGF7 very effec-
tively induces ectopic Pea3, and to a lesser extent, Erm
expression in the proximal endoderm, while control beads
soaked with BSA have no effect (Fig. 3A and B). A much
weaker response is seen with FGF10 (Fig. 3E and F). By
contrast, FGF9 weakly induces ectopic Erm and Pea3 ex-
pression in proximal epithelium, but gives strong upregula-
tion of Pea3 in the mesenchyme adjacent to the bead. As
expected, given its broader specificity for receptors, FGF2
induces ectopic Pea3 and Erm in both the endoderm and
mesoderm, with the strongest effect on Pea3 (Fig. 3G–J).
Taken together, these results show that the two genes are
downstream of FGF signaling in the lung and respond
differentially to specific FGFs both in culture and in the
intact lung.
Abnormal development of SpC-EngR-Erm transgenic lung
The overlapping expression patterns of Erm and Pea3
described above suggest that they have redundant roles in
lung development. This idea is supported by the fact that
Pea3/ mice survive postnatally and show no overt dif-
ference in growth rate and state of health, which would not
be expected if they had lung abnormalities (Laing et al.,
2000). It is also possible that members of other, more
divergent, ETS protein subfamilies expressed in the embry-
onic lung (Elf, Ehf) (Ng et al., 2002) compensate for loss of
Pea3 members. We therefore decided to take a transgenic
approach to study the function of Erm in embryonic lung,
using the well-characterized 3.7-kb human SpC promoter/
enhancer (Wert et al., 1993). This drives transgene expres-
sion in the distal epithelium, but only at high levels from
E15.5. We first expressed either full-length Erm protein or
a truncated protein containing the ETS DNA binding do-
main, but lacking both the N-terminal activation domain
and a small portion of the C terminus, which is considered
to have slight activity for transcriptional activation. At
E18.5, no abnormalities are observed in the lungs of em-
bryos transgenic for either of these expression constructs. In
the case of the full-length protein, these results may be
because the expression level of the transgene is not high
enough or may reflect the fact that the level of endogenous
Erm is already saturating. For the truncated protein, it is
likely that a very high level of expression is needed to affect
cell behavior. This idea is supported by our in vitro studies,
showing that the deletion mutant blocks less than 20% of
Erm-mediated activation of a Pea3-artificial promotor-lucif-
erase reporter (Fig. 4B). These in vitro studies also con-
firmed that, in an epithelial cell line derived from adult
mouse lung, Erm acts as an activator of a reporter construct
(Fig. 4C).
We then made transgenic embryos expressing a protein
consisting of truncated Erm fused with the repressor domain
of Drosophila Engrailed (EngR) (Fig. 4A). Our in vitro
studies demonstrated that EngR-Erm is about five times
more effective at blocking Erm induction of the luciferase
reporter than the deletion mutant (Fig. 4B). A similar ap-
proach has been used successfully to generate repressor
forms of ETS proteins and to study the function of ETS
protein during sea urchin development (Wei et al., 1999),
mammary gland tumorigenesis (Shepherd et al., 2001), and
neural crest stem cell differentiation (Paratore et al., 2002).
Six of a total of nine transgenic lungs at E18.5 showed an
abnormal gross phenotype, being smaller than nontransgen-
ics and paler, but with a normal lobular morphology (Fig.
4D and E). The expression of the transgene is confirmed by
section in situ hybridization using the SV40 small T intron
as the probe (Fig. 4F and G). Higher levels of transgene
expression correlate with a more severe phenotype.
Histological analysis at E18.5 reveals several significant
differences between transgenic and normal lungs. First, the
control lungs contain many small saccules (primitive alve-
oli) separated by a thin layer of mesenchyme. The epithelial
cells lining the saccules are characteristic of squamous Type
I cells interspersed by differentiated Type II cells. By con-
trast, transgenic lungs have clearly undergone less extensive
branching of the epithelium and contain fewer, larger sacs
separated by abundant mesenchyme and lined with cuboidal
epithelial cells resembling epithelial precursors or immature
Type II cells. In addition, the proximal epithelium extends
closer to the pleural surface of the lung than normal, and the
transition from proximal to cuboidal cells is abrupt. No
difference is observed in the morphology of the convoluted
epithelium of the proximal airways in transgenic and wild
type lungs (Fig. 5).
To examine the ultrastructural morphology of the epithe-
lial cells, transmission electron microscopy (EM) was per-
formed at E18.5. This confirmed that control distal epithe-
lium at this stage is lined with squamous Type I cells,
interspersed by mature Type II cells. In contrast, the distal
epithelium of the transgenic lungs is composed solely of
cuboidal cells resembling immature Type II cells, some
cells contain a few atypical lamellar bodies compared with
mature cells. The morphology of the proximal epithelial
Fig. 6. Ultrastructural morphology of control and transgenic lung epithelial cells. (A, B) Ethylene blue-stained 500 nm sections of distal regions of control
(A) and transgenic (B) lungs. (C–F) Transmission electron microscopy images from these sections. Proximal cells taken approximately within the red squares
are shown for nontransgenic (C) and transgenic (D) lungs. Note the presence of ciliated cells (arrows). (E, F) From distal regions taken approximately within
the green squares in (A) and (B). (E) shows a mature type II cell in the control lung epithelium characterized by lamellar bodies (red arrowhead). The distal
epithelium of transgenic lung is composed of cuboidal cells resembling immature type II cells (F). Only a few atypical lamellar bodies were seen (red arrow).
Scale bar, 25 m.
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cells of the transgenic lungs is not significantly different
from wild type and both ciliated cells and nonciliated cells
were present (Fig. 6). Together, these results suggest that
expression of SpC-EngR-Erm result in the specific disrup-
tion of the differentiation of mature alveolar Type I and II
cells.
Expression of the proximal markers, CC10 and Foxj1, in
EngR-Erm transgenic lungs
To analyze epithelial differentiation at the molecular
level, we examined expression of two markers for proximal
endoderm, Foxj1 and CC10, Foxj1 encodes a winged helix
transcription factor expressed from about E15 in the ciliated
cells of the proximal airway, but not in distal epithelium
(Hackett et al., 1995). CC10 is a secreted glycoprotein
characteristic of nonciliated Clara cells of the proximal
epithelium and is expressed from E17.5 (Wert et al., 1993).
Both Foxj1 and CC10 are expressed in transgenic lungs,
apparently at higher levels than normal (Fig. 7). The pres-
ence of CC10 protein in transgenic lungs is confirmed by
CC10 antibody staining (Fig. 8A and B). Moreover, the
relative proportion of cells that express the proximal
marker, Foxj1, is higher in transgenic lungs, compared with
controls (see Materials and methods). In situ hybridization
of adjacent sections of a transgenic lung reveals that neither
transgene nor SpC are transcribed in the epithelial cells
expressing Foxj1 (Fig. 7).
Abnormal differentiation of mature distal epithelial cells
in transgenic lungs
Early in lung development, the epithelium is composed
of a morphologically uniform population of precursor cells
that express SpC. After E17.5, these give rise distally to
flattened Type I alveolar cells that are specialized for gas
exchange and characteristically express Aquaporin 5
(Aqp5), a water channel protein. These flattened cells are
interspersed with rounded Type II cells, specialized for
surfactant protein synthesis and expressing very high levels
of SpC. In transgenic lungs, the layer of relatively uniform
cuboidal cells that lines the dilated distal sacs and expresses
the transgene expresses SpC (Fig. 7). However, no signifi-
cant expression of Aqp5 is seen, compared with control
lungs (Fig. 8C and D). Taken together with the EM mor-
phology, these results suggest that the population of distal
cells in transgenic lungs at E18.5 consists of relatively
undifferentiated precursor cells, and that EngR-Erm delays
or inhibits their differentiation into mature Type I and Type
II cells.
Cell proliferation in transgenic lungs
We estimated the mitotic index of cells of transgenic and
control lungs by phosphohistone H3 antibody staining at
E18.5 (Fig. 8E and F). The results indicate that the trans-
genic distal epithelial cells have an approximately sixfold
higher proliferation rate than controls at this time. The
mitotic index of the proximal epithelial cells is also in-
creased by about ninefold in transgenic lungs at E18.5,
compared with wild type. The mesenchymal cells appear to
have elevated proliferation as well, although this is not
quantitated. No difference in apoptosis between wild type
and transgenic lungs is seen by immunohistochemistry with
antibody to cleaved caspase-3 protein (data not shown).
Discussion
Pea3 sub-family members are new players in the
epithelial–mesenchymal interactions at the distal tip of
lung buds
Although Pea3 family members are known to be ex-
pressed at sites of mesenchymal–epithelial interactions in
several organs, including salivary gland, gut, lung, inner
ear, and the olfactory organ (Chotteau-Lelievre et al., 1997),
their roles in morphogenesis have not been investigated
previously. In this paper, we show that Erm and Pea3 have
overlapping expression in the distal endoderm of the devel-
oping lung from as early as E10.5 after the buds have first
appeared, while Pea3 (like Er81) is also expressed in the
mesoderm. (Chotteau-Lelievre et al., 1997; de Launoit et
al., 1997). Moreover, we demonstrate that transgenic ex-
pression of a repressor form of Erm (EngR-Erm) results in
a severe disruption of lung development. In addition to
defects in branching morphogenesis, the differentiation of
distal cell types is inhibited or delayed. Consequently, by
E18.5, the distended terminal airways are lined almost en-
tirely by cuboidal cells that express SpC but lack normal
lamellar bodies, and squamous Type I cells transcribing
Aquaporin 5 are absent. However, the differentiation of
proximal cell types expressing CC10 and Foxj1 does occur.
Indeed, there is an increase in the relative proportion of
proximal endodermal cells compared with distal.
One model to explain the transgenic phenotype is illus-
trated in Fig. 9. Based on the expression pattern of Erm/
Pea3 and on lineage studies in vivo (Perl et al., 2002), we
propose that Erm/Pea3 act within a population of precursor
cells at the tip of lung buds. These cells will give rise to
mature Type I and Type II cells, and also have the potential
to differentiate into proximal cell types. Erm/Pea3 normally
functions cell autonomously as part of the program main-
taining the distal precursor phenotype, and later to promote
the differentiation of distal precursor cells into mature Type
I and Type II cells. In transgenic lungs, SpC-EngR-Erm
reduces the size of the precursor cell population and inhibits
or delays the differentiation of mature distal cells, but still
allows the precursor cells to differentiate into proximal cell
types. Consequently, by E18.5, there is an increase in the
relative proportion of proximal versus distal cells in trans-
genic lungs. The idea that EngR-Erm has a differential
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effect on the differentiation of distal versus proximal lin-
eages is consistent with recent studies on the role of Erm in
neural crest stem cells (NCSCs) (Paratore et al., 2002).
These authors show that the dominant repressor form of
Erm blocks the differentiation of multipotent NCSCs into
neurons, but not into glia cells.
One paradox of our results is that we observe high
epithelial proliferation rates at E18.5 in transgenic lungs,
even though the overall size of the lung is smaller than
normal. One possibility is that Pea3/Erm normally help to
maintain the higher proliferation rate of distal versus prox-
imal epithelial cells during the pseudoglandular stage, but
later, wild-type cells differentiate and their proliferation rate
is reduced. In transgenic lungs, the population of prolifer-
ating precursor cells is smaller than normal but they still
maintain a relatively high rate of proliferation up to E18.5.
Based on some studies showing that Pea3/Erm regulate
the expression of matrix metalloproteinases (de Launoit et
al., 2000; Crawford et al., 2001), it is also possible that
Pea3/Erm regulate some of the dynamic cell–cell and cell–
matrix interactions that are crucial for normal branching
morphogenesis. For example, This might account for the
fact that, when Erm/Pea3 action is blocked, there is less
branching and large, dilated distal sacs are formed. The
disruption of Type I epithelial cell differentiation and Aqua-
porin 5 expression might then be secondary to the disrupted
distal morphogenesis. However, this mechanism alone does
not account for the specific phenotype that we see compared
with other transgenic lungs in which branching morphogen-
esis is disrupted as a result of ectopic transgene expression.
For example, in SpC-TGF- (Zhou et al., 1996) SpC-
HNF-3 (Zhou et al., 1997) transgenic lungs, and the lungs
in which a transgene encoding a Gata6-Engrailed repressor
fusion protein is overexpressed with the SpC promoter
(Yang et al., 2002), the expression of both proximal and
distal markers are reduced. In these examples, the distal
epithelial cells may be blocked at an earlier developmental
stage than the SpC-EngR-Erm transgenic lungs, and differ-
entiation of both proximal and distal cell types is impaired.
We cannot rule out the possibility that the EngR-Erm
transgene negatively regulates its own expression, since
FGF7 upregulates SpC expression in isolated endoderm
(Fig. 2E). However, if this is the case, then the transgenic
phenotype that we observe is milder than might be expected
for high expression of a dominant repressor protein.
Specificity of EngR-Erm action
The engrailed domain has been used frequently to block
the function of various families of transcription factors,
including ETS domain proteins (Wei et al., 1999; Novitch et
al., 2001; Muhr et al., 2001; Yang et al., 2002). Maintenance
of the functional specificity of DNA binding domains after
fusion with the engrailed repressor domain has been shown
for the bHLH proteins, Olig1 and Olig2 (Novitch et al.,
2001). Expression of the Engrailed domain by itself does
not cause lung developmental defects (Yang et al., 2002).
However, our results do not rule out the possibility that, by
expressing a repressor form of Erm, targets of some other
ETS proteins, that recognize identical cis regulatory se-
quences, are also repressed. The most likely candidates are
the targets of Pea3, whose expression overlap with Erm in
the epithelium, although in a more restricted domain. In
support of this idea, studies in mammary cell lines have
shown that a Pea3-EngR fusion protein inhibits activation of
a reporter by both Erm and Er81. Importantly, the Pea3-
EngR fusion protein did not recognize the binding site for
another ETS protein, GABP-, in the MMTV promotor,
even when expressed at high levels (Shepherd et al., 2001).
Other ETS factors present in embryonic mouse lung epithe-
lium are Ets2, Elf3, and the closely related Ehf (Ng et al.,
2002), but based on molecular phylogeny, these proteins are
more distantly related to Erm/Pea3 than GABP- (Laudet et
al., 1999). For these reasons, we consider the ETS proteins
most likely to be blocked by EngR-Erm in our study are
Erm and Pea3. In addition, any ETS protein that EngR-Erm
does block is also likely to be one that has the ability to
compensate for Erm/Pea3 loss.
Fig. 7. Gene expression in E18.5 control and transgenic lungs. Radioactive
section in situ hybridization was performed by using probes for (A, D)
CC10; (B, E, H) Foxj1; (C, F, I) SpC; and (G) SV40 T intron. (A–C)
control lung, (D–I) transgenic lungs. (D–F) and (G–I) are from two inde-
pendent transgenic lines and (G–I) are adjacent sections. (A–C) were
processed at the same time as (D–F). (A–F) In transgenic lungs, the
expression levels of CC10 and Foxj1 are significantly higher than in wild
type. Cells expressing SpC are present in large, distended sacs in the
transgenic lungs but in numerous primitive alveoli in wild type. Arrows in
(G–I) indicate the same regions of proximal endoderm that express Foxj1
but not SpC or small T intron. By contrast, the latter two genes are
coexpressed in the epithelial cells associated with the distended sacs. Scale
bar, 100 m.
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Fig. 8. Differentiation and proliferation of proximal and distal epithelial cells in transgenic lungs. (A, B) CC10 antibody staining of control (A) and transgenic
(B) lungs. (C, D) Section in situ hybridization of control (C) and transgenic (D) lungs using Aquaporin 5 as probe. (E, F) Proliferation of epithelial cells in
control and transgenic lungs estimated by double labeling with anti phosphahistone H3 antibody and DAPI of control (E) and transgenic lungs (F). Yellow
arrowheads indicate phosphohistone positive mesenchymal cells; white arrowheads indicate phosphohistone positive cells that line sacs, and are presumably
epithelial cells. Nuclear staining is shown as blue. Autofluorescence of red blood cells shows as a characteristic red staining. Scale bar, 100 m.
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All Pea3 sub-family members have been genetically
inactivated in mice. Erm null mutant dies at E9.5, before
lung development starts (T. Jessel, personal communica-
tion). Pea3/male mice are infertile, probably because of
neuronal dysfunction, but apparently do not have a lung
phenotype (Laing et al., 2000), suggesting that Pea3 and
Erm have redundant functions during lung development. In
addition, Ets2/ mice have been generated by chimera
rescue and show no overt phenotype in organogenesis
(Yamamoto et al., 1998), and the Elf3/mouse also show
no lung abnormalities (Ng et al., 2002). Our approach of
using a repressor protein overcomes the problems of poten-
tial functional redundancy and early lethality with Pea3
family members and has allowed us to uncover for the first
time a role for ETS proteins in lung branching morphogen-
esis.
Regulation of Erm and Pea3 by FGFs during lung
development
Given the fact that Pea3 family members are downstream
of FGF signaling in other tissues, we explored the possibil-
ity that expression of these genes in distal lung endoderm is
maintained by FGF signaling from the mesoderm. Our stud-
ies support this hypothesis, but also show that expression in
the epithelium responds differently to FGF7 and FGF10,
even though both ligands can bind to FGF receptor 2b, an
isoform that is expressed in the endoderm and is absolutely
required for early lung development (Ornitz and Itoh, 2001
for review; Ornitz et al., 1996; Igarashi et al., 1998; De
Moerlooze et al., 2000). This differential response was seen
in both isolated endoderm and in intact lungs in vitro. In
isolated endoderm, Pea3 and, to a lesser extent, Erm, are
Fig. 9. A model for the function of Pea3/Erm in distal epithelium and the phenotype of Spc-EngR-Erm transgenic lungs. Pea3/Erm, possibly responding to
Fgf7 in mesoderm (brown arrow), act to maintain the phenotype of the distal endodermal progenitor cells population (blue). As lung bud outgrowth continues,
some progeny of these cells are displaced proximally (yellow arrow) and differentiate into proximal cell types (yellow). Shortly before birth, the precursor
pool gives rise (black arrow) to mature Type I and Type II cells (green and black) that will contribute to the future alveoli. In SpC-EngR-Erm transgenic lungs,
maintenance of the precursor phenotype is inhibited, but not differentiation of the distal into proximal cells. The reduced overall size of the precursor pool,
coupled with inhibition of differentiation of mature Type I and II cells, blocks the development of future alveoli. As a result, the distal part of the transgenic
lung is composed of relatively undifferentiated cells and the proportion of the proximal cells is higher than wild type.
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strongly upregulated in response to FGF7, which also pro-
motes the expression of the distal markers, SpC and Bmp4,
and the formation of cysts with numerous small buds. By
contrast, FGF10 promotes the formation of elongated buds,
and is much less effective than FGF7 in upregulating ex-
pression of Bmp4, Pea3, and Erm. The fact that differential
effects are seen both in isolated endoderm and in intact
embryonic lungs suggests that the results are not an artifact
of culturing endoderm in the presence of Matrigel compo-
nents, such as heparan sulfate proteoglycans and other ex-
tracellular matrix components that may alter the binding of
FGFs to specific receptors (Igarashi et al., 1998).
The different effects of FGF7 and FGF10 on morphology
and SpC and/or Bmp4 expression have been observed pre-
viously with tracheal endoderm (Hyatt et al., 2002) but have
not been reported before for genes encoding transcription
factors. Taken together, the results suggest that FGF10 is
mainly responsible for the initiation and outgrowth of epi-
thelial buds, while FGF7 is mainly responsible for the main-
tenance of the expression of distal-specific genes and dif-
ferentiation of distal cell types (Ulich et al., 1994; Simonet
et al., 1995; Shiratori et al., 1996; Bellusci et al., 1997;
Cardoso et al., 1997; Park et al., 1998; Shannon et al., 1999;
Sekine et al., 1999; Tichelaar et al., 2000; Weaver et al.,
2000). Since FGF7 is more effective than FGF10 for the
induction of Pea3/Erm expression, the phenotype that we
observed in our transgenic lung may result from a partial
block of FGF7 signaling, while FGF10 signaling remains
largely intact. In other words, Pea3/Erm may preferentially
mediate signaling events between mesenchyme and epithe-
lium that involve FGF7.
Potential target genes for Erm and Pea3 in the embryonic
lung
Our results suggest that Erm and/or Pea3 regulate the
expression of two classes of downstream targets. During the
pseudoglandular stage, they may positively regulate prod-
ucts required to maintain a high rate of cell proliferation and
an undifferentiated, multipotent phenotype in a population
of distal progenitor cells. Later in development, they may
promote the expression of genes driving the differentiation
of mature Type II and Type I alveolar epithelial cells and/or
the expression of products characteristic of these mature cell
types. Recent studies have identified an important role for
the matrix metalloproteinase, MMP7 or matrilysin, in epi-
thelial cells in adult lung (Li et al., 2002). Studies in mam-
mary epithelial cell lines have shown that Erm promotes the
expression of MMP in response to Wnt signaling (Crawford
et al., 2001). This raises the possibility that Erm also regu-
lates metalloproteinase expression in the embryonic and
adult lung in vivo. However, analysis of transgenic EngR-
Erm lungs by in situ hybridization showed no inhibition in
the level of MMP14 transcripts, which is known to be
expressed in lung epithelium at E18.5 (Kheradmand et al.,
2001). Further analysis of gene expression in wild type and
transgenic lungs will therefore be necessary to identify
potential downstream targets of the Pea3 family in vivo.
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